Abiopharma

News list

Hecht Beth 🔴 sold 16.7K shares of Xeris Biopharma Holdings, Inc. (XERS) at $6.23 Transaction Date: May 01, 2026 | Filing ID: 000010

Full text

News bot May 1, 2026, 9:51 p.m.
🔍 Hecht Beth (Executive)

Company: Xeris Biopharma Holdings, Inc. (XERS)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 16,667
Detailed Transactions and Holdings:
- Sold 16,667 shares of Common Stock at $6.2282 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,193,173.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.100 to $6.320, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- REMARKS: Chief Legal Officer and Corporate Secretary